VERA
VERA
NASDAQ · Biotechnology

Vera Therapeutics Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks
$38.43
+3.34 (+9.52%)
As of Jun 22, 9:59 PM ET ·
Analyst Consensus
Strong Buy
20
Analysts
High
Coverage
Buy 18 90%
Hold 2 10%
Sell 0 0%
Price Target
Analyst Price Target +146.2% upside
Low Target $72.50
Average Target $94.61
High Target $144.94
Current Price $38.43
Current
$38.43
Target
$94.61
$72.50 $94.61 avg $144.94
Scenario Analysis
Bear Case
$72.50
88.7%
Low target
Base Case
$94.61
+146.2%
Avg target
Bull Case
$144.94
+277.2%
High target
Risk/Reward
3.1x
Highly favorable
Price in Context
52-Week High
$56.05
-31.4% from high
52-Week Low
$19.07
+101.6% from low
50-Day SMA
$46.91
-18.1% vs SMA
200-Day SMA
$30.68
+25.3% vs SMA
RSI (14)
41.5
Neutral
Target vs 52W High
$94.61
+68.8% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 78% $257.58 +12.0%
AMGN
Amgen Inc
 Hold 44 50% $190.87 -44.6%
GILD
Gilead Sciences Inc
 Strong Buy 39 82% $362.68 +190.4%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 40 83% $438.34 -6.1%
REGN
Regeneron Pharmaceuticals
 Buy 38 71% $76.80 -87.5%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 37 76% $102.31 -64.3%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -31.2%
NTRA
Natera Inc
 Strong Buy 27 89% $142.91 -37.5%